Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T19:48:53.732Z.
Calculation as of: 2026-10-06T19:48:53.732Z.
Quote observation: 2026-10-06T19:43:44.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f8447282adf6e47d1ec21ed7020f0f216562717f012d53baf90ed137265b4b00
PEG RATIO
N/A
Profusa, Inc. Common Stock
Market Cap
$1.85M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Profusa, Inc. Common Stock (PFSA) | $1.85M | N/A |
| Beyond Air, Inc. (XAIR)vs › | $1.89M | N/A |
| Tenon Medical, Inc. (TNON)vs › | $1.88M | N/A |
| Autonomix Medical, Inc. (AMIX)vs › | $1.90M | N/A |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.86M | N/A |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.78M | N/A |
| Silo Pharma, Inc. (SILO)vs › | $1.60M | N/A |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.12M | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.11M | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.50M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
